Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.21.73 (
urokinase-type plasminogen activator
)
10,685
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Demyelinating injuries and diseases, like multiple sclerosis, affect millions of people worldwide. Oligodendrocyte precursor cells (OPCs) have the potential to repair demyelinated tissues because they can both self-renew and differentiate into oligodendrocytes (OLs), the myelin producing cells of the central nervous system (CNS). Cell-matrix interactions impact OPC differentiation into OLs, but the process is not fully understood. Biomaterial hydrogel systems help to elucidate cell-matrix interactions because they can mimic specific properties of native CNS tissues in an
in vitro
setting. We investigated whether OPC maturation into OLs is influenced by interacting with a
urokinase plasminogen activator
(
uPA
) degradable extracellular matrix (ECM).
uPA
is a proteolytic enzyme that is transiently upregulated in the developing rat brain, with peak
uPA
expression correlating with an increase in myelin production
in vivo
. OPC-like cells isolated through the Mosaic Analysis with Double Marker technique (
MADM
OPCs) produced low-molecular-weight
uPA
in culture.
MADM
OPCs were encapsulated into two otherwise similar elastin-like protein (ELP) hydrogel systems: one that was
uPA
degradable and one that was nondegradable. Encapsulated
MADM
OPCs had similar viability, proliferation, and metabolic activity in
uPA
degradable and nondegradable ELP hydrogels. Expression of OPC maturation-associated genes, however, indicated that
uPA
degradable ELP hydrogels promoted
MADM
OPC maturation although not sufficiently for these cells to differentiate into OLs.
...
PMID:Guiding Oligodendrocyte Precursor Cell Maturation With Urokinase Plasminogen Activator-Degradable Elastin-like Protein Hydrogels. 3281 63